Whole-exome sequencing (WES) performed in individuals with a clinical suspicion of SMS but without a molecular diagnosis highlighted potentially deleterious variants in different genes, including KMTD2, MECP2, KDM5C, IQSEC2, and DEAF1 [120,121]. This evidence concerns the gene MECP2 and Smith-Magenis syndrome.